Premium
Singapore state investment firm Temasek Holdings has picked up a minority stake in an Indian drug research company, thereby increasing its exposure to the healthcare sector in the country.Temasek has bought a 2.4% stake in Syngene International Ltd, majority owned by Biocon Ltd, for around Rs 220 crore ($35 million), ......
This is a Premium article. Please subscribe or log in to read the full story!
Here's a selection of our recent premium content.
Already a member? Click here to log in.
